abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Esta página no está disponible en Español y está siendo mostrada en English

Artículo

19 Dic 2011

Autor:
B-HRD (Business and Human Rights Documentation Project)

In Focus: Big Pharma and Access to HIV/AIDS Drugs

Ver todas las etiquetas
Millions in the developing world depend on affordable generic medicines. As multinational pharmaceutical companies pursue strategies to protect patents for key drugs in India and Brazil, access to essential medicines is frustrated and concerns regarding the rising cost of life-saving drugs intensify. [with sections on "Business Impacts on Human Rights"; "Demanding Justice"; and "Human Rights Defenders"]